HOCPY (HOCPY) Stock Price & Analysis
HOCPY (HOCPY) fell 5.13% to USD 158.4 as of June 10, 2026 at 00:54 UTC, according to Nexqual real-time market data.
HOCPY last closed at USD 166.97; the session ranged USD 156.32–163.18 on volume of 8,159 shares. Market capitalization is $52.99B, with a 52-week range of USD 110.85–190.18 (PNK). Source: Nexqual, June 10, 2026 at 00:54 UTC.
Key Statistics (as of June 10, 2026 at 00:54 UTC)
| Price | USD 158.4 |
|---|---|
| Change | ▼ 5.13% (down) |
| Previous Close | USD 166.97 |
| Open | USD 160.47 |
| Day Range | USD 156.32 – 163.18 |
| 52-Week Range | USD 110.85 – 190.18 |
| Volume | 8,159 shares |
| Market Cap | $52.99B |
| Exchange | PNK |
Technical Analysis (HOCPY)
Nexqual's technical model rates HOCPY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:54 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.7 (neutral) |
| vs SMA50 | Below (USD 175.93) |
| MACD | -3.72 (negative) |
Analyst Ratings (HOCPY)
Wall Street analysts rate HOCPY "Strong Buy" based on 1 analysts, with a mean price target of USD 201.94 (range USD 201.94–201.94), per Nexqual as of June 10, 2026 at 00:54 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 201.94 |
| High Target | USD 201.94 |
| Low Target | USD 201.94 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (HOCPY)
| Next Earnings Date | 2026-07-31 |
|---|---|
| Revenue Estimate | $248.99B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1 vs est 1.1 ▼ miss |
| 2025-12-31 | USD 1.77 vs est 1.05 ▲ beat |
| 2025-09-30 | USD 1.05 vs est 0.99 ▲ beat |
| 2025-06-30 | USD 1 vs est 1.05 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Financials & Fundamentals (HOCPY)
| Total Revenue | $947.75B |
|---|---|
| Revenue Growth (YoY) | +14.20% |
| Gross Margin | +54.97% |
| Operating Margin | +46.70% |
| Profit Margin | +26.70% |
| ROE | +25.06% |
| Debt / Equity | 4.08 |
| Current Ratio | 4.81 |
| Total Cash | $574.09B |
| Total Debt | $42.24B |
| Free Cash Flow | $174.87B |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Financial Health Score (HOCPY)
Nexqual rates HOCPY's overall financial health "Strong" across five dimensions, as of June 10, 2026 at 00:54 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 55%, operating 47% |
| Balance Sheet | Strong — $574.1B cash vs $42.2B debt, net cash position |
| Cash Flow | Strong — FCF $174.9B, 18% margin |
| Efficiency | Strong — ROE 25%, ROA 15.5% |
Ownership (HOCPY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.07% |
| Shares Outstanding | 334.51M |
| Float | 335.48M |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Leadership (HOCPY)
HOCPY is led by Eiichiro Ikeda (age 55), Representative Executive Officer, President, CEO & Chairperson of Board of Directors, per Nexqual as of June 10, 2026 at 00:54 UTC.
| Representative Executive Officer, President, CEO & Chairperson of Board of Directors | Eiichiro Ikeda (age 55) |
|---|---|
| Representative Executive Officer, CFO & Director | Ryo Hirooka (age 51) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| TRUMY | Terumo Corp. | USD 14.17 | ▲ 1.07% |
| SHECY | Shin-Etsu Chemical Co., Ltd. | USD 21.11 | ▼ 4.22% |
| CSLLY | CSL Ltd. | USD 17.44 | ▲ 1.87% |
| SMCAY | SMC Corp | USD 19.41 | ▼ 1.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:54 UTC. This page is informational and not investment advice.